Bumrungrad Hospital PCL (BH)

Currency in THB
145.50
+1.00(+0.69%)
Delayed Data·
BH Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 14 days
Fair Value
Day's Range
143.50147.00
52 wk Range
130.00284.00
Key Statistics
Bid/Ask
152.50 / 138.50
Prev. Close
144.5
Open
144
Day's Range
143.5-147
52 wk Range
130-284
Volume
1.9M
Average Vol. (3m)
3.88M
1-Year Change
-41.5%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
200.60
Upside
+37.87%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple

Bumrungrad Hospital PCL News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Bumrungrad Hospital PCL Company Profile

Bumrungrad Hospital Public Company Limited owns and operates hospitals in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, paediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopaedics, perinatal, plastic surgery, pulmonary, refractive surgery, memory, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, IVF, hearing and balance, medical, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, and vaccine clinics and centers. In addition, it operates spine institute, heart institute, and intensive care unit; and offers nutrition services, pharmacy services, preventive genomics and integrative medicine services. Further, the company offers clinical research, hospital consulting and management, healthcare personnel development and training, healthcare referral, and digital platform services. Additionally, it is involved in the distribution of pharmaceutical and medical goods in specialized stores; development of software for healthcare services; holding of real estate assets; and manufacture and sale of vitamin supplements. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.

Employees
3253
Market
Thailand

Bumrungrad Hospital PCL Earnings Call Summary for Q1/2025

  • Q1 2025 revenue fell 5.6% to $208.01M, with EPS at $2.18, missing $2.36 forecast; stock dropped 2.96% after-hours to $164
  • International patient revenue declined 9.7%, while Thai patient revenue increased 1.2%; EBITDA and net profit margins both fell 12.6%
  • Company maintains strong financial health with 1.16 current ratio and more cash than debt, despite current challenges
  • Bumrungrad became first in Thailand to install Siemens photon counting CT, emphasizing commitment to innovation
  • Outlook focuses on improving visa processing for international patients and engaging more with Saudi Arabian market
Last Updated: 05/02/2025, 03:42 AM
Read Full Transcript

Compare BH to Peers and Sector

Metrics to compare
BH
Peers
Sector
Relationship
P/E Ratio
15.3x15.0x−0.5x
PEG Ratio
10.06−0.230.00
Price / Book
3.9x1.7x2.6x
Price / LTM Sales
4.5x1.4x3.2x
Upside (Analyst Target)
34.5%23.8%45.4%
Fair Value Upside
Unlock29.0%6.7%Unlock

Analyst Ratings

13 Buy
6 Hold
1 Sell
Ratings:
20 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 200.60
(+37.87% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 9.46%
Dividend Yield
3.46%
Annualized Payout
5.00
Paid unevenly
5-Years Growth
+9.34%
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
2.18 / 2.36
Revenue / Forecast
6.12B / 6.34B
EPS Revisions
Last 90 days

BH Income Statement

People Also Watch

27.75
KTC
+3.74%
119.00
SCB
+1.28%
21.00
COM7
+0.96%
50.50
CPN
+2.54%
7.35
HMPRO
+2.08%

FAQ

What Is the Bumrungrad Hospital (BH) Stock Price Today?

The Bumrungrad Hospital stock price today is 145.50

What Stock Exchange Does Bumrungrad Hospital Trade On?

Bumrungrad Hospital is listed and trades on the Thailand Stock Exchange stock exchange.

What Is the Stock Symbol for Bumrungrad Hospital?

The stock symbol for Bumrungrad Hospital is "BH."

Does Bumrungrad Hospital Pay Dividends? What’s The Current Dividend Yield?

The Bumrungrad Hospital dividend yield is 3.46%.

What Is the Bumrungrad Hospital Market Cap?

As of today, Bumrungrad Hospital market cap is 115.67B.

What Is Bumrungrad Hospital's Earnings Per Share (TTM)?

The Bumrungrad Hospital EPS (TTM) is 9.46.

When Is the Next Bumrungrad Hospital Earnings Date?

Bumrungrad Hospital will release its next earnings report on Jul 31, 2025.

From a Technical Analysis Perspective, Is BH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Bumrungrad Hospital Stock Split?

Bumrungrad Hospital has split 1 times.

How Many Employees Does Bumrungrad Hospital Have?

Bumrungrad Hospital has 3253 employees.

What is the current trading status of Bumrungrad Hospital (BH)?

As of Jul 17, 2025, Bumrungrad Hospital (BH) is trading at a price of 145.50, with a previous close of 144.50. The stock has fluctuated within a day range of 143.50 to 147.00, while its 52-week range spans from 130.00 to 284.00.

What Is Bumrungrad Hospital (BH) Price Target According to Analysts?

The average 12-month price target for Bumrungrad Hospital is THB200.6, with a high estimate of THB300 and a low estimate of THB150. 13 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +37.87% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.